scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1019531341 |
P356 | DOI | 10.1007/S00296-009-1129-7 |
P698 | PubMed publication ID | 19777240 |
P50 | author | Janet Pope | Q48742471 |
P2093 | author name string | Murray Baron | |
Xiangning Fan | |||
Canadian Scleroderma Research Group | |||
P2860 | cites work | Mortality in systemic sclerosis: an international meta-analysis of individual patient data | Q30980001 |
Assessment of damage and activity in systemic sclerosis | Q34090246 | ||
Systemic sclerosis: current views of its pathogenesis | Q35171947 | ||
Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale | Q35549965 | ||
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. | Q35550511 | ||
European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria | Q35553047 | ||
Systemic sclerosis: a prototypic multisystem fibrotic disorder | Q35649427 | ||
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned | Q35673286 | ||
Scleroderma--clinical and pathological advances | Q35781664 | ||
Changes in causes of death in systemic sclerosis, 1972-2002 | Q35954516 | ||
Clinical trials in systemic sclerosis: lessons learned and outcomes | Q36130965 | ||
Update on indices of disease activity in systemic sclerosis | Q36760739 | ||
Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review | Q36961479 | ||
Factors predicting development of renal involvement in progressive systemic sclerosis | Q39343777 | ||
The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time | Q39455773 | ||
Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee | Q39513167 | ||
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. | Q39632069 | ||
Disease assessment indices: activity, damage and severity. | Q40471904 | ||
Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma | Q41438736 | ||
What does the clinician need to improve patient care in systemic sclerosis? | Q42111569 | ||
Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis | Q43537993 | ||
Severe restrictive lung disease in systemic sclerosis. | Q50600064 | ||
Scleroderma: health services utilization from patients' perspective. | Q51801397 | ||
Localized scleroderma severity index and global assessments: a pilot study of outcome instruments. | Q53035231 | ||
Development and validation of a self-administered systemic sclerosis questionnaire (SySQ). | Q53546654 | ||
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis | Q68330753 | ||
A disease severity scale for systemic sclerosis: development and testing | Q73101147 | ||
The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis | Q73463792 | ||
How to assess musculoskeletal conditions. Assessment of disease activity | Q73481988 | ||
Systemic sclerosis (scleroderma) and related disorders: clinical aspects | Q73958785 | ||
Disease severity as a predictor of outcome in scleroderma | Q77601190 | ||
Disease-specific quality indicators, guidelines and outcome measures in scleroderma | Q79898177 | ||
The scleroderma Assessment Questionnaire (SAQ). A new self-assessment questionnaire for evaluation of disease status in patients with systemic sclerosis | Q82663613 | ||
P433 | issue | 9 | |
P304 | page(s) | 1205-1210 | |
P577 | publication date | 2009-09-24 | |
P1433 | published in | Rheumatology International | Q15763689 |
P1476 | title | What is the relationship between disease activity, severity and damage in a large Canadian systemic sclerosis cohort? Results from the Canadian Scleroderma Research Group (CSRG) | |
P478 | volume | 30 |
Q37686449 | Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme |
Q36758822 | The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis |
Q40002833 | The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis |
Search more.